POLB and colorectal cancer: However, a small molecule inhibitor of Polβ, NSC666715 (with an IC50 of ∼4 μM), designed by in silico molecular docking blocks the strand-displacement activity of Polβ in LP-BER leading to AP site accumulation and S-phase cell cycle arrest in colorectal cancers [62].